mhurhangee/ep-ind-claims huggingface dataset:
Method for narrow-surface coating of planar semifinished products or workpieces made of wood or of wood materials such as chipboard or medium-density fibreboard, using edge-banding machines or machining systems in which the planar semifinished products that are already coated with two top layers pass in a continuous manner through a plurality of work stations, the prepared narrow surfaces being bonded to the narrow-surface material that is to be applied, under the effect of pressure and temperature and by means of a hot-melt adhesive that is heated directly or indirectly, and the narrow surface and the adjacent top layers of the planar semifinished product being machined, characterised in that, before, during or after a machining process at least the regions of the planar semifinished product that are to be machined or that have been machined are cooled by a flow of carbon dioxide or of a mixture of carbon dioxide and air, the carbon dioxide being in liquid form and the cooling effect being achieved by means of liquid carbon dioxide being converted to gaseous carbon dioxide.
A stabilization system for an equipment positioner with motorized axes, the positioner being oriented under the action of a command of orientation following a line of sight/pointing, said positioner being installed on a vehicle, the vehicle undergoing movements referred to as bearing movements, the positioner including angle encoders producing angle measurements (θ p, θ t) for its controlled axes and a set of gyrometer sensors producing measurements of equipment instantaneous rates of rotation (m y, m z), said gyrometer sensors exhibiting biases ( p y, p z), the positioner including gyrometer sensors for at least two axes (y) (z) of the equipment reference system, the positioner including a calculation unit with intra-positioner means for servo control-correction of the instantaneous rates of rotation of the equipment using measurements and the command of orientation for stabilizing the equipment following the line of sight, the system being intended to be installed in the vehicle that includes a means for measuring the vehicle attitude, giving measurements of attitude of the vehicle, characterized in that the system includes calculation means for controlling the positioner according to a control law that allows correcting the bias ( p̂ y, p̂ z) thanks to vehicle attitude information and by implementing a state observer combining an equipment attitude estimation ( q) and the measurements of equipment rates of rotation (m y, m z) so as to determine the biases of the gyrometer sensors of the positioner and to correct them within the control law, the equipment attitude estimation ( q) being obtained, in the calculation means of the system, by calculation directly based on the vehicle attitude measurements (Ψ, θ, Φ) and the angle measurements (θ p, θ t) of the controlled positioning axes of the positioner.
A device for storing and applying viscous substances which are to be mixed from at least two components during application, with two carrier sections (2a, 2b), whereof one comprises at least two initially upwardly open recesses (3a, 3b; 4a, 4b) and the other comprises at least one upwardly open recess (3a, 3b), so that in each case one of the components can be introduced from above into one recess (3a, 3b) of the two carrier sections (2a, 2b) and thereafter the recesses (3a, 3b) containing the components can be closed to the exterior each with one or with a common cover film thereby forming in each case a first chamber (3a', 3b'), in such a way that a connecting channel (8a, 8b) remains between in each case the first chamber (3a', 3b') and the in each case adjacent further recess (4a, 4b), said connecting channel opening via a predetermined rupture point when pressure is applied on the respective first chamber (3a', 3b'), and so the components present in the two first chambers (3a', 3b') can be mixed in a third chamber and/or already in the mutually connected connecting channels (8a, 8b), which third chamber is formed by placing upon one another the two carrier sections (2a, 2b) with their upper sides and the at least one or the two further recesses (4a, 4b) which are thereby turned upside down becoming congruent, wherein the third chamber can also be closed to the exterior following the placing upon one another or folding upon one another of the two carrier sections (2a, 2b).
A sulfonamide pharmaceutical composition, comprising the following raw materials: Raw materials Percentage by weight sulfonamide compound 20%-40% PEG-400 20%-40% 1,2-propanediol 5%-10% Sebacic acid 2%-5% 2-ethyl-1,3-hexanediol 10%-20% Dimethyl sulfoxide 0-10% Anhydrous ethanol 0-10% wherein the sulfonamide pharmaceutical composition is prepared by a process comprising the steps of: 1) adding the sulfonamide compound, PEG-400, and 2-ethyl-1, 3-hexanediol into a container, stirring slowly at 85°C-95°C to form a miscible solution, Solution A, for later use; 2) adding sebacic acid and 1,2-propanediol into a separate container, stirring slowly at 85°C-95°C to form a miscible solution, Solution B, for later use; 3) mixing Solution A and Solution B while maintaining the temperature at 85°C-95°C, and stirring to obtain a homogenous solution for later use; 4) adding dimethyl sulfoxide and a part of a predetermined amount of anhydrous ethanol into a container, stirring and mixing well to obtain a homogenous solution, Solution C, for later use; 5) cooling the mixture of Solution A and Solution B to 60°C, adding Solution C to the mixture, stirring and mixing well before cooling down to room temperature, adding the remaining amount of anhydrous ethanol and mixing well; 6) filtering with 0.45 μm microporous membrane, aliquoting into 5 ml ampoules and sealing the ampoules; and 7) sterilizing at 121°C for 30 minutes. wherein the sulfonamide compound is selected from one, or a mixture of two or more, at any ratio, of the following: wherein R=H, C 2 H 5, or 1) adding the sulfonamide compound, PEG-400, and 2-ethyl-1, 3-hexanediol into a container, stirring slowly at 85°C-95°C to form a miscible solution, Solution A, for later use; 2) adding sebacic acid and 1,2-propanediol into a separate container, stirring slowly at 85°C-95°C to form a miscible solution, Solution B, for later use; 3) mixing Solution A and Solution B while maintaining the temperature at 85°C-95°C, and stirring to obtain a homogenous solution for later use; 4) adding dimethyl sulfoxide and a part of a predetermined amount of anhydrous ethanol into a container, stirring and mixing well to obtain a homogenous solution, Solution C, for later use; 5) cooling the mixture of Solution A and Solution B to 60°C, adding Solution C to the mixture, stirring and mixing well before cooling down to room temperature, adding the remaining amount of anhydrous ethanol and mixing well; 6) filtering with 0.45 μm microporous membrane, aliquoting into 5 ml ampoules and sealing the ampoules; and 7) sterilizing at 121°C for 30 minutes.
A device for interrupting the flow of electricity in a circuit, the device being configured for mounting in a cutout coupled to the circuit, including a first external electrical contact and a second external electrical contact, the first and second external electrical contacts being coupled to a vacuum interrupter disposed within an housing of the device, the vacuum interrupter having a first contact movable relative to a second contact for making or breaking an electrical circuit between the first external electrical contact and the second external electrical contact and responsive to a force exerted upon the first contact by an actuator (172, 300, 400) coupled to the first contact, the device having a trunnion for engaging a hinge portion of the cutout, the trunnion formed with motion limiting structures that engage the hinge portion upon dropout of the device from the cutout to limit rotation of the device within the hinge portion.
A positive active material for a rechargeable lithium battery, comprising an overlithiated layered oxide represented by the following Chemical Formula 1: Chemical Formula 1 Li a Ni b Co c Mn d M e O 2 wherein in Chemical Formula 1, 1.1< a <1.2, 0.1< b <0.2, 0.1≤ c <0.2, 0.4<d<0.6, 0.002≤ e ≤0.007 and 0.8≤ b + c + d + e <1 or 1.1< a <1.2, 0.1<b<0.2, 0.1≤ c <0.2, 0.4<d<0.6, 0.008≤ e ≤0.012 and 0.8≤ b + c + d + e <1, and M is a cation element of vanadium, gallium (Ga), zirconium (Zr), magnesium (Mg), aluminum (Al), titanium (Ti), chromium (Cr), iron (Fe), tungsten, molybdenum (Mo), silicon (Si), or a combination thereof. an overlithiated layered oxide represented by the following Chemical Formula 1: Chemical Formula 1 Li a Ni b Co c Mn d M e O 2 wherein in Chemical Formula 1, 1.1< a <1.2, 0.1< b <0.2, 0.1≤ c <0.2, 0.4<d<0.6, 0.002≤ e ≤0.007 and 0.8≤ b + c + d + e <1 or 1.1< a <1.2, 0.1<b<0.2, 0.1≤ c <0.2, 0.4<d<0.6, 0.008≤ e ≤0.012 and 0.8≤ b + c + d + e <1, and M is a cation element of vanadium, gallium (Ga), zirconium (Zr), magnesium (Mg), aluminum (Al), titanium (Ti), chromium (Cr), iron (Fe), tungsten, molybdenum (Mo), silicon (Si), or a combination thereof. 1.1< a <1.2, 0.1< b <0.2, 0.1≤ c <0.2, 0.4<d<0.6, 0.002≤ e ≤0.007 and 0.8≤ b + c + d + e <1 or 1.1< a <1.2, 0.1<b<0.2, 0.1≤ c <0.2, 0.4<d<0.6, 0.008≤ e ≤0.012 and 0.8≤ b + c + d + e <1, and M is a cation element of vanadium, gallium (Ga), zirconium (Zr), magnesium (Mg), aluminum (Al), titanium (Ti), chromium (Cr), iron (Fe), tungsten, molybdenum (Mo), silicon (Si), or a combination thereof.
A method of predicting the likelihood of long-term survival of a cancer patient without the recurrence of ovarian or breast cancer, comprising: a) determining the expression levels of at least two iron homeostasis associated markers provided in Table I in a sample obtained from said patient; and b) comparing the expression levels of said at least two IHA markers in said sample to predetermined expression levels of IHA markers observed in a cohort of cancer patients having a known clinical outcome of recurrent or non-recurrent disease, thereby determining said patient's risk for recurrence of cancer; wherein a) said cancer is breast cancer and the two or more IHA markers are selected from the group consisting of (i) ferroportin and hepcidin, (ii) ferroportin, CyBRD1, STEAP1, STEAP2, ISCU and TFR, or (iii) DcytB, TFRC and LTF; or b) said cancer is ovarian cancer and the two or more IHA markers include ferroportin. a) determining the expression levels of at least two iron homeostasis associated markers provided in Table I in a sample obtained from said patient; and b) comparing the expression levels of said at least two IHA markers in said sample to predetermined expression levels of IHA markers observed in a cohort of cancer patients having a known clinical outcome of recurrent or non-recurrent disease, thereby determining said patient's risk for recurrence of cancer; wherein a) said cancer is breast cancer and the two or more IHA markers are selected from the group consisting of (i) ferroportin and hepcidin, (ii) ferroportin, CyBRD1, STEAP1, STEAP2, ISCU and TFR, or (iii) DcytB, TFRC and LTF; or b) said cancer is ovarian cancer and the two or more IHA markers include ferroportin. a) said cancer is breast cancer and the two or more IHA markers are selected from the group consisting of (i) ferroportin and hepcidin, (ii) ferroportin, CyBRD1, STEAP1, STEAP2, ISCU and TFR, or (iii) DcytB, TFRC and LTF; or (i) ferroportin and hepcidin, (ii) ferroportin, CyBRD1, STEAP1, STEAP2, ISCU and TFR, or (iii) DcytB, TFRC and LTF; or b) said cancer is ovarian cancer and the two or more IHA markers include ferroportin.
A liquid electrolyte fuel cell with means to define an electrolyte chamber, and comprising two electrodes, one electrode on either side of the electrolyte chamber, each electrode comprising a sheet of electrically conducting material through which are defined a multiplicity of through-pores, the sheet having a peripheral margin without through-pores, and wherein the electrodes are removable from the electrolyte-chamber-defining means, characterised in that each electrode also comprises a coating of catalytic material to define a catalyst-carrying face of the electrode, the coating including carbon and a binder, such that in use of the cell, liquid electrolyte is present at one face of the electrode and gas is present at the other face of the electrode, such that there is an interface between gas and liquid electrolyte at a constant position in the vicinity of the catalyst.
A method comprising: instantiating a plurality of instances of a same radio protocol, and simultaneously operating the plurality of instances of the same radio protocol with an underlying physical layer, where each instance of the same radio protocol is embodied in a same code module and where each instance has associated protocol data stored in a memory, where operating comprises executing each instance of the same radio protocol so that a portion of physical layer resources are shared between different instances of the same radio protocol, and scheduling access of the instances of the same radio protocol to the physical layer resources in a time-sliced manner, the physical layer resources being at least one signal processing block or at least one hardware accelerator. instantiating a plurality of instances of a same radio protocol, and simultaneously operating the plurality of instances of the same radio protocol with an underlying physical layer, where each instance of the same radio protocol is embodied in a same code module and where each instance has associated protocol data stored in a memory, where operating comprises executing each instance of the same radio protocol so that a portion of physical layer resources are shared between different instances of the same radio protocol, and scheduling access of the instances of the same radio protocol to the physical layer resources in a time-sliced manner, the physical layer resources being at least one signal processing block or at least one hardware accelerator.
A nucleic acid aptamer molecule comprising a polynucleotide sequence capable of specifically binding a polypeptide participating in influenza virus infection of cells, wherein said polynucleotide binds a region of hemagglutinin as defined by amino acid coordinates 91-261 of SEQ ID NO: 1, wherein the nucleic acid aptamer is capable of preventing influenza virus infection of cells in vitro and in vivo.
An inductive heating assembly for generating an aerosol from an aerosol precursor material in an aerosol provision system, the inductive heating assembly comprising: a susceptor (330, 340, 350, 360); and a drive coil arranged to induce current flow in the susceptor to heat the susceptor and vaporise aerosol precursor material in proximity with a surface of the susceptor, and wherein the susceptor comprises regions of different susceptibility (331, 332, 341, 342, 351, 352, 361, 362) to induced current flow from the drive coil, such that when in use the surface of the susceptor in the regions of different susceptibility are heated to different temperatures by the current flow induced by the drive coil. a susceptor (330, 340, 350, 360); and a drive coil arranged to induce current flow in the susceptor to heat the susceptor and vaporise aerosol precursor material in proximity with a surface of the susceptor, and wherein the susceptor comprises regions of different susceptibility (331, 332, 341, 342, 351, 352, 361, 362) to induced current flow from the drive coil, such that when in use the surface of the susceptor in the regions of different susceptibility are heated to different temperatures by the current flow induced by the drive coil.
An improved locking nut and sealing washer for use with a threaded portion of a bolt, where: the locking nut has an external profile and a flange and the sealing washer has a washer body, a retainer wall and an elastomer, the retainer wall extends from the periphery of a first side of the washer body, the retainer wall also having retaining means provided in an interior surface thereof, the elastomer extends from an internal profile of the washer body in a direction away from the retainer wall and is thereby interposed between a surface and the washer body when in use, where, when the locking nut is seated on the sealing washer, a removable retaining insert may be manipulated to be received within the retaining means and where, when torque is applied to an appropriate portion of the external profile to move the locking nut in a first direction along the threaded portion of the bolt towards the surface, the flange pushes against the washer body to push the sealing washer in the same direction and, when torque is applied to the locking nut in an opposing direction along the threaded portion of the bolt, the flange pushes against the retaining insert to push the sealing washer in the same direction. the locking nut has an external profile and a flange and the sealing washer has a washer body, a retainer wall and an elastomer, the retainer wall extends from the periphery of a first side of the washer body, the retainer wall also having retaining means provided in an interior surface thereof, the elastomer extends from an internal profile of the washer body in a direction away from the retainer wall and is thereby interposed between a surface and the washer body when in use,
A method of mass spectrometry comprising: determining the accurate or exact mass or mass to charge ratio of a first substance or ion, wherein said accurate or exact mass or mass to charge ratio comprises a first integer nominal mass or mass to charge ratio component and a first decimal mass or mass to charge ratio component; and searching for one or more second substances or ions having a decimal mass or mass to charge ratio component which is between 0 to x 1 mDa or milli-mass to charge ratio units greater than said first decimal mass or mass to charge ratio component and/or between 0 to x 2 mDa or milli-mass to charge ratio units lesser than said first decimal mass or mass to charge ratio component, wherein the method further comprises applying a decimal mass or mass to charge ratio window to mass spectral data or a mass spectrum, wherein said decimal mass or mass to charge ratio window filters out, removes, attenuates or at least reduces the significance of second substances or ions having a decimal mass or mass to charge ratio component which falls outside of said decimal mass or mass to charge ratio window; wherein the accurate or exact mass or mass to charge ratio of said first substance or ion minus the accurate or exact mass or mass to charge ratio of a second substance or ion has a value of ΔM Daltons or mass to charge ratios units, wherein x 1 and/or x 2 varies as a function of ΔM in a symmetrical or asymmetrical manner. determining the accurate or exact mass or mass to charge ratio of a first substance or ion, wherein said accurate or exact mass or mass to charge ratio comprises a first integer nominal mass or mass to charge ratio component and a first decimal mass or mass to charge ratio component; and searching for one or more second substances or ions having a decimal mass or mass to charge ratio component which is between 0 to x 1 mDa or milli-mass to charge ratio units greater than said first decimal mass or mass to charge ratio component and/or between 0 to x 2 mDa or milli-mass to charge ratio units lesser than said first decimal mass or mass to charge ratio component, wherein the method further comprises applying a decimal mass or mass to charge ratio window to mass spectral data or a mass spectrum, wherein said decimal mass or mass to charge ratio window filters out, removes, attenuates or at least reduces the significance of second substances or ions having a decimal mass or mass to charge ratio component which falls outside of said decimal mass or mass to charge ratio window; wherein the accurate or exact mass or mass to charge ratio of said first substance or ion minus the accurate or exact mass or mass to charge ratio of a second substance or ion has a value of ΔM Daltons or mass to charge ratios units, wherein x 1 and/or x 2 varies as a function of ΔM in a symmetrical or asymmetrical manner.
A compound represented by the following Chemical Formula 1 for an organic optoelectric device: wherein, in the above Chemical Formula 1, R 1 to R 16 are independently hydrogen, deuterium, a substituted or unsubstituted C1 to C10 alkyl group, a substituted or unsubstituted C6 to C20 aryl group, or -SiR 17 R 18 R 19, the R 17 to R 19 are independently substituted or unsubstituted C1 to C6 alkyl group, one of the R 1 to R 8 is a functional group represented by the following Chemical Formula 2, and another of the R 1 to R 8 is -SiR 17 R 18 R 19, one of R 9 to R 16 is a functional group represented by the following Chemical Formula 2, and another of the R 9 to R 16 is -SiR 17 R 18 R 19 L is a bidentate ligand of a monovalent anion, and is a ligand coordination-bonding with iridium through a unshared electron pair of carbon or heteroatom, and n and m are independently integers of 0 to 3, and n + m is one of integers of 1 to 3, wherein, in the above Chemical Formula 2, R 20 to R 24 are independently hydrogen, deuterium, a substituted or unsubstituted C1 to C10 alkyl group, or a substituted or unsubstituted C6 to C20 aryl group, and * denotes position bonding with a carbon atom. R 1 to R 16 are independently hydrogen, deuterium, a substituted or unsubstituted C1 to C10 alkyl group, a substituted or unsubstituted C6 to C20 aryl group, or -SiR 17 R 18 R 19, the R 17 to R 19 are independently substituted or unsubstituted C1 to C6 alkyl group, one of the R 1 to R 8 is a functional group represented by the following Chemical Formula 2, and another of the R 1 to R 8 is -SiR 17 R 18 R 19, one of R 9 to R 16 is a functional group represented by the following Chemical Formula 2, and another of the R 9 to R 16 is -SiR 17 R 18 R 19 L is a bidentate ligand of a monovalent anion, and is a ligand coordination-bonding with iridium through a unshared electron pair of carbon or heteroatom, and n and m are independently integers of 0 to 3, and n + m is one of integers of 1 to 3, wherein, in the above Chemical Formula 2, R 20 to R 24 are independently hydrogen, deuterium, a substituted or unsubstituted C1 to C10 alkyl group, or a substituted or unsubstituted C6 to C20 aryl group, and * denotes position bonding with a carbon atom. R 20 to R 24 are independently hydrogen, deuterium, a substituted or unsubstituted C1 to C10 alkyl group, or a substituted or unsubstituted C6 to C20 aryl group, and * denotes position bonding with a carbon atom.